Sure. I like the point about us as a moving target too. We should develop, release and administer antibiotics strategically to take advantage of our insights into how antibiotic resistance develops. But…
One man’s boon to humanity is another man’s business model --or political football. This, more than any scientific challenge, is what concerns me.
